These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 16261405)

  • 1. The time-related changes of the importance of prognostic factors in breast cancer. A sequential multivariate analysis of 1423 Japanese patients.
    Takeuchi H; Baba H; Kano T; Maehara Y
    Breast Cancer Res Treat; 2005 Dec; 94(3):273-8. PubMed ID: 16261405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Time-dependent relevance of prognostic factors in patients with gastric cancer.
    Takeuchi H; Kakeji Y; Maehara Y
    Hepatogastroenterology; 2008; 55(82-83):779-81. PubMed ID: 18613453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogen receptor, progesterone receptor, HER-2, and response to postmastectomy radiotherapy in high-risk breast cancer: the Danish Breast Cancer Cooperative Group.
    Kyndi M; Sørensen FB; Knudsen H; Overgaard M; Nielsen HM; Overgaard J;
    J Clin Oncol; 2008 Mar; 26(9):1419-26. PubMed ID: 18285604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High prognostic significance of residual disease after neoadjuvant chemotherapy: a retrospective study in 710 patients with operable breast cancer.
    Abrial SC; Penault-Llorca F; Delva R; Bougnoux P; Leduc B; Mouret-Reynier MA; Mery-Mignard D; Bleuse JP; Dauplat J; Curé H; Chollet P
    Breast Cancer Res Treat; 2005 Dec; 94(3):255-63. PubMed ID: 16267618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Twenty-five years of follow-up in patients with operable breast carcinoma: correlation between clinicopathologic factors and the risk of death in each 5-year period.
    Arriagada R; Le MG; Dunant A; Tubiana M; Contesso G
    Cancer; 2006 Feb; 106(4):743-50. PubMed ID: 16411216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic factors for patients with liver metastases from breast cancer.
    Eichbaum MH; Kaltwasser M; Bruckner T; de Rossi TM; Schneeweiss A; Sohn C
    Breast Cancer Res Treat; 2006 Mar; 96(1):53-62. PubMed ID: 16319993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical characteristics and prognosis of breast cancer patients with vascular invasion].
    Zhao WH; Xu BH; Zhang P; Li Q; Zhao LM; Sun Y
    Zhonghua Zhong Liu Za Zhi; 2007 Feb; 29(2):137-40. PubMed ID: 17645853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical features and prognosis in breast cancer patients over 70 years of age].
    Zhao WH; Xu BH; Li Q; Zhang P; Sun Y
    Zhonghua Zhong Liu Za Zhi; 2006 May; 28(5):385-8. PubMed ID: 17045008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A retrospective review with long term follow up of 11,400 cases of pure mucinous breast carcinoma.
    Di Saverio S; Gutierrez J; Avisar E
    Breast Cancer Res Treat; 2008 Oct; 111(3):541-7. PubMed ID: 18026874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A study on the relationship between breast cancer molecular classification and prognosis].
    Chen XS; Ma CD; Chen CM
    Zhonghua Wai Ke Za Zhi; 2008 Sep; 46(18):1400-3. PubMed ID: 19094512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Local recurrence after mastectomy for breast cancer: analysis of clinicopathological, biological and prognostic characteristics.
    Carreño G; Del Casar JM; Corte MD; González LO; Bongera M; Merino AM; Juan G; Obregón R; Martínez E; Vizoso FJ
    Breast Cancer Res Treat; 2007 Mar; 102(1):61-73. PubMed ID: 16850244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy.
    Lee KH; Im SA; Oh DY; Lee SH; Chie EK; Han W; Kim DW; Kim TY; Park IA; Noh DY; Heo DS; Ha SW; Bang YJ
    BMC Cancer; 2007 Apr; 7():63. PubMed ID: 17430582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The importance of prognostic factors in premenopausal women with breast cancer.
    Finek J; Holubec L; Topolcan O; Elgrova L; Skalova A; Pecen L
    Anticancer Res; 2007; 27(4A):1893-6. PubMed ID: 17649790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinicopathological and biological features of breast cancer in young females and their relationship with prognosis].
    Meng J; Lang RG; Fan Y; Fu L
    Zhonghua Zhong Liu Za Zhi; 2007 Apr; 29(4):284-8. PubMed ID: 17760256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Analysis of prognostic factors in breast cancer at University Hospital for Tumors].
    Lesar M; Stanec M; Oresić T
    Acta Med Croatica; 2006; 60(1):35-41. PubMed ID: 16802570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen receptor beta--an independent prognostic marker in estrogen receptor alpha and progesterone receptor-positive breast cancer?
    Maehle BO; Collett K; Tretli S; Akslen LA; Grotmol T
    APMIS; 2009 Sep; 117(9):644-50. PubMed ID: 19703124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apolipoprotein D predicts adverse outcome in women >or=70 years with operable breast cancer.
    Søiland H; Janssen EA; Kørner H; Varhaug JE; Skaland I; Gudlaugsson E; Baak JP; Søreide JA
    Breast Cancer Res Treat; 2009 Feb; 113(3):519-28. PubMed ID: 18330697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ten years of experience with weekly chemotherapy in metastatic breast cancer patients: multivariate analysis of prognostic factors.
    Nisticò C; Cuppone F; Bria E; Fornier M; Giannarelli D; Mottolese M; Novelli F; Natoli G; Cognetti F; Terzoli E
    Anticancer Drugs; 2006 Nov; 17(10):1193-200. PubMed ID: 17075319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of KLF5 is a prognostic factor for disease-free survival and overall survival in patients with breast cancer.
    Tong D; Czerwenka K; Heinze G; Ryffel M; Schuster E; Witt A; Leodolter S; Zeillinger R
    Clin Cancer Res; 2006 Apr; 12(8):2442-8. PubMed ID: 16638850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical detection using the new rabbit monoclonal antibody SP1 of estrogen receptor in breast cancer is superior to mouse monoclonal antibody 1D5 in predicting survival.
    Cheang MC; Treaba DO; Speers CH; Olivotto IA; Bajdik CD; Chia SK; Goldstein LC; Gelmon KA; Huntsman D; Gilks CB; Nielsen TO; Gown AM
    J Clin Oncol; 2006 Dec; 24(36):5637-44. PubMed ID: 17116944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.